XML 25 R44.htm IDEA: XBRL DOCUMENT
v2.4.1.9

Business Segments (Details) (USD $) In Thousands, unless otherwise specified | 3 Months Ended | 9 Months Ended |
--- | --- | --- | ---
Mar. 31, 2015 | Mar. 31, 2014 | Mar. 31, 2015 | Mar. 31, 2014 | Jun. 30, 2014
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | $ 187,495 us-gaap_Revenues | $ 173,267 us-gaap_Revenues | $ 563,641 us-gaap_Revenues | $ 508,237 us-gaap_Revenues |
Adjusted EBITDA | 27,496 pahc_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization | 22,444 pahc_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization | 82,982 pahc_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization | 66,352 pahc_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization |
Depreciation and amortization | (5,356)us-gaap_DepreciationDepletionAndAmortization | (5,122)us-gaap_DepreciationDepletionAndAmortization | (15,950)us-gaap_DepreciationDepletionAndAmortization | (15,615)us-gaap_DepreciationDepletionAndAmortization |
Interest expense, net | (3,602)us-gaap_InterestIncomeExpenseNet | (8,744)us-gaap_InterestIncomeExpenseNet | (10,607)us-gaap_InterestIncomeExpenseNet | (26,198)us-gaap_InterestIncomeExpenseNet |
Foreign currency gains (losses), net | 4,633 us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet | (275)us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet | 6,855 us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet | (2,088)us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet |
Acquisition related accrued compensation | (327)us-gaap_BusinessCombinationAcquisitionRelatedCosts |  | (327)us-gaap_BusinessCombinationAcquisitionRelatedCosts |  |
Income before income taxes | 22,844 us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | 8,303 us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | 62,953 us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | 22,451 us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest |
Identifiable assets | 472,338 us-gaap_Assets |  | 472,338 us-gaap_Assets |  | 472,323 us-gaap_Assets
Operating Segments | Animal Health |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 117,346 us-gaap_Revenues / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = pahc_AnimalHealthMember | 107,808 us-gaap_Revenues / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = pahc_AnimalHealthMember | 353,356 us-gaap_Revenues / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = pahc_AnimalHealthMember | 316,945 us-gaap_Revenues / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = pahc_AnimalHealthMember |
Adjusted EBITDA | 29,629 pahc_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = pahc_AnimalHealthMember | 25,505 pahc_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = pahc_AnimalHealthMember | 90,379 pahc_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = pahc_AnimalHealthMember | 74,134 pahc_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = pahc_AnimalHealthMember |
Identifiable assets | 351,881 us-gaap_Assets / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = pahc_AnimalHealthMember |  | 351,881 us-gaap_Assets / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = pahc_AnimalHealthMember |  | 361,376 us-gaap_Assets / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = pahc_AnimalHealthMember
Operating Segments | Mineral Nutrition |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 57,320 us-gaap_Revenues / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = pahc_MineralNutritionMember | 49,901 us-gaap_Revenues / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = pahc_MineralNutritionMember | 171,509 us-gaap_Revenues / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = pahc_MineralNutritionMember | 146,720 us-gaap_Revenues / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = pahc_MineralNutritionMember |
Adjusted EBITDA | 3,761 pahc_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = pahc_MineralNutritionMember | 2,807 pahc_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = pahc_MineralNutritionMember | 10,994 pahc_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = pahc_MineralNutritionMember | 8,145 pahc_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = pahc_MineralNutritionMember |
Identifiable assets | 58,887 us-gaap_Assets / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = pahc_MineralNutritionMember |  | 58,887 us-gaap_Assets / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = pahc_MineralNutritionMember |  | 57,460 us-gaap_Assets / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = pahc_MineralNutritionMember
Operating Segments | Performance Products |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 12,829 us-gaap_Revenues / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = pahc_PerformanceProductsMember | 15,558 us-gaap_Revenues / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = pahc_PerformanceProductsMember | 38,776 us-gaap_Revenues / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = pahc_PerformanceProductsMember | 44,572 us-gaap_Revenues / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = pahc_PerformanceProductsMember |
Adjusted EBITDA | 994 pahc_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = pahc_PerformanceProductsMember | 906 pahc_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = pahc_PerformanceProductsMember | 2,192 pahc_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = pahc_PerformanceProductsMember | 3,105 pahc_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = pahc_PerformanceProductsMember |
Identifiable assets | 21,827 us-gaap_Assets / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = pahc_PerformanceProductsMember |  | 21,827 us-gaap_Assets / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = pahc_PerformanceProductsMember |  | 23,429 us-gaap_Assets / us-gaap_ConsolidationItemsAxis = us-gaap_OperatingSegmentsMember / us-gaap_StatementBusinessSegmentsAxis = pahc_PerformanceProductsMember
Corporate |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Adjusted EBITDA | (6,888)pahc_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization / us-gaap_ConsolidationItemsAxis = us-gaap_CorporateNonSegmentMember | (6,774)pahc_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization / us-gaap_ConsolidationItemsAxis = us-gaap_CorporateNonSegmentMember | (20,583)pahc_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization / us-gaap_ConsolidationItemsAxis = us-gaap_CorporateNonSegmentMember | (19,032)pahc_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization / us-gaap_ConsolidationItemsAxis = us-gaap_CorporateNonSegmentMember |
Identifiable assets | $ 39,743 us-gaap_Assets / us-gaap_ConsolidationItemsAxis = us-gaap_CorporateNonSegmentMember |  | $ 39,743 us-gaap_Assets / us-gaap_ConsolidationItemsAxis = us-gaap_CorporateNonSegmentMember |  | $ 30,058 us-gaap_Assets / us-gaap_ConsolidationItemsAxis = us-gaap_CorporateNonSegmentMember

X
- Definition Adjusted earnings before interest taxes depreciation and amortization. + References No definition available. + Details
Name: | pahc_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
Namespace Prefix: | pahc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.18) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 12 -Article 7 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 18 -Article 5 + Details
Name: | us-gaap_Assets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 25 -Paragraph 23 -URI http://asc.fasb.org/extlink&oid=34752592&loc=d3e1043-128460 + Details
Name: | us-gaap_BusinessCombinationAcquisitionRelatedCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 + Details
Name: | us-gaap_DepreciationDepletionAndAmortization
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Aggregate impact of foreign currency derivatives on earnings for the period. Includes impact of foreign currency cash flow hedge ineffectiveness and the ineffectiveness of fair value hedging derivatives and full change in fair value of the foreign currency derivatives not designated as hedging instruments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4A -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5618551-113959 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5624171-113959 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 25 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6886632&loc=d3e76258-113986 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4D -Subparagraph (a)(2) -URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5624177-113959 + Details
Name: | us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 940 -SubTopic 20 -Section 25 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=35710027&loc=d3e41242-110953 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 10 -Article 5 + Details
Name: | us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The net amount of operating interest income (expense). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.10) -URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 10 -Article 9 + Details
Name: | us-gaap_InterestIncomeExpenseNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 + Details
Name: | us-gaap_Revenues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_SegmentReportingInformationLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |